P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS by Steven Hwang, Jacqueline Wang, Zizhong Tian, Xinyue Qi, Yi Jiang, Shijia Zhang, Richard C. Godby, Sameer Parikh, Wei Ding, Paul Hampel, Javier Munoz, Jonas Paludo, Saad Kenderian, Eli Muchtar, Mazie Tsang, Talal Hilal, Jose Leis, Gita Thanarajasingam, David Inwards, Grzegorz S. Nowakowski, Stephen Ansell, Thomas Habermann, Thomas Witzig, Neil Kay, Shouhao Zhou, Yucai Wang

Get full text